Fried G M, Hreno A, Duguid W P, Hampson L G
Surgery. 1984 Oct;96(4):815-22.
We reviewed the long-term results of management of 38 patients with carcinoma in colorectal polyps. Of these, 16 patients demonstrated malignant invasion of the lamina propria but not the muscularis mucosa (group I), and 22 patients showed malignant invasion of the muscularis mucosa (group II). Primary therapy for group I patients consisted of polypectomy in 12, local excision in one, and colonic resection in three. One patient had a subsequent abdominal-perineal resection and was found to have no residual disease and no lymph node involvement. Follow-up of the group I patients showed that 11 were alive and well (mean 5.8 years) and five died of unrelated causes (mean 5.2 years). Of group II patients, 12 underwent polypectomy, six local excision, and four colectomy. Of these 22 patients, 11 underwent further operation, including nine major bowel resections and two local re-excisions. None of these 11 patients had either residual tumor or lymph node metastases. One patient died of complications after abdominal-perineal resection. Follow-up showed that 18/22 group II patients were alive and well 5 to 15 years later (mean 7.5 years); four died of unrelated causes (mean 3.2 years). We then reviewed another group of 220 patients who had undergone resection for invasive colon cancer to relate the presence or absence of lymph node metastases to the depth of malignant invasion in the bowel wall. We found that 44% of this entire group had lymph node involvement. Of 36 patients with tumor confined to the bowel wall, nodal metastases occurred in only 22%. Of eight patients with malignancy superficial to the muscularis propria, only one had nodal involvement. We conclude that colon cancer tends to progress in an orderly fashion and the risk of nodal metastases increases with the depth of invasion. Carcinoma in a polyp represents a very early stage of colon cancer. We therefore recommend polypectomy as primary treatment for pedunculated polyps containing carcinoma either superficial to or invading muscularis mucosa. If histologic review demonstrates incomplete excision, lymphatic invasion, or poor differentiation, patients with lesions invading the muscularis mucosa should undergo formal colonic resection.
我们回顾了38例大肠息肉癌患者的长期治疗结果。其中,16例患者表现为癌组织侵犯黏膜固有层,但未侵犯黏膜肌层(I组),22例患者表现为癌组织侵犯黏膜肌层(II组)。I组患者的主要治疗方法包括12例行息肉切除术、1例行局部切除术、3例行结肠切除术。1例患者随后接受了腹会阴联合切除术,结果发现无残留病灶且无淋巴结转移。对I组患者的随访显示,11例存活且状况良好(平均5.8年),5例死于无关原因(平均5.2年)。II组患者中,12例行息肉切除术,6例行局部切除术,4例行结肠切除术。在这22例患者中,11例接受了进一步手术,包括9例大肠大部切除术和2例局部再次切除术。这11例患者均无残留肿瘤或淋巴结转移。1例患者在腹会阴联合切除术后死于并发症。随访显示,II组22例患者中有18例在5至15年后存活且状况良好(平均7.5年);4例死于无关原因(平均3.2年)。然后,我们回顾了另一组220例接受浸润性结肠癌切除术的患者,以探讨有无淋巴结转移与肠壁恶性浸润深度之间的关系。我们发现,整个这组患者中有44%发生了淋巴结转移。在36例肿瘤局限于肠壁的患者中,仅22%发生了淋巴结转移。在8例肿瘤侵犯黏膜肌层浅面的患者中,只有1例发生了淋巴结转移。我们得出结论,结肠癌往往呈有序进展,淋巴结转移的风险随浸润深度增加而增加。息肉内的癌代表结肠癌的一个非常早期阶段。因此,我们建议对含有侵犯黏膜肌层浅面或侵犯黏膜肌层的癌的带蒂息肉,以息肉切除术作为主要治疗方法。如果组织学检查显示切除不完全、有淋巴管浸润或分化差,侵犯黏膜肌层的病变患者应接受正规的结肠切除术。